Literature DB >> 23192027

Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii.

John Badger1, Barbara Chie-Leon, Cheyenne Logan, Vandana Sridhar, Banumathi Sankaran, Peter H Zwart, Vicki Nienaber.   

Abstract

Acinetobacter baumannii is a Gram-negative pathogenic bacterium which is resistant to most currently available antibiotics and that poses a significant health threat to hospital patients. LpxA is a key enzyme in the biosynthetic pathway of the lipopolysaccharides that are components of the bacterial outer membrane. It is a potential target for antibacterial agents that might be used to fight A. baumannii infections. This paper describes the structure determination of the apo form of LpxA in space groups P2(1)2(1)2(1) and P6(3). These crystal forms contained three and one protein molecules in the asymmetric unit and diffracted to 1.8 and 1.4 Å resolution, respectively. A comparison of the conformations of the independent protein monomers within and between the two crystal asymmetric units revealed very little structural variation across this set of structures. In the P6(3) crystal form the enzymatic site is exposed and is available for the introduction of small molecules of the type used in fragment-based drug discovery and structure-based lead optimization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192027      PMCID: PMC3509968          DOI: 10.1107/S174430911204571X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  22 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Discovering novel ligands for macromolecules using X-ray crystallographic screening.

Authors:  V L Nienaber; P L Richardson; V Klighofer; J J Bouska; V L Giranda; J Greer
Journal:  Nat Biotechnol       Date:  2000-10       Impact factor: 54.908

3.  Crystal structure of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori.

Authors:  Byung Il Lee; Se Won Suh
Journal:  Proteins       Date:  2003-11-15

Review 4.  High-throughput crystallography for lead discovery in drug design.

Authors:  Tom L Blundell; Harren Jhoti; Chris Abell
Journal:  Nat Rev Drug Discov       Date:  2002-01       Impact factor: 84.694

5.  Fragment-based lead discovery using X-ray crystallography.

Authors:  Michael J Hartshorn; Christopher W Murray; Anne Cleasby; Martyn Frederickson; Ian J Tickle; Harren Jhoti
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

6.  Structure of UDP-N-acetylglucosamine acyltransferase with a bound antibacterial pentadecapeptide.

Authors:  Allison H Williams; Robert M Immormino; Daniel T Gewirth; Christian R H Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

7.  Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis.

Authors:  Venkatasubramanian Ulaganathan; Lori Buetow; William N Hunter
Journal:  J Mol Biol       Date:  2007-03-21       Impact factor: 5.469

Review 8.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 10.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  3 in total

1.  Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA).

Authors:  Alice Ngo; Kai T Fong; Daniel L Cox; Xi Chen; Andrew J Fisher
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-04-24

2.  Structure-Based Virtual Screening of Pseudomonas aeruginosa LpxA Inhibitors Using Pharmacophore-Based Approach.

Authors:  Baki Vijaya Bhaskar; Tirumalasetty Muni Chandra Babu; Aluru Rammohan; Gui Yu Zheng; Grigory V Zyryanov; Wei Gu
Journal:  Biomolecules       Date:  2020-02-10

3.  Discovery of dual-activity small-molecule ligands of Pseudomonas aeruginosa LpxA and LpxD using SPR and X-ray crystallography.

Authors:  Kyle G Kroeck; Michael D Sacco; Emmanuel W Smith; Xiujun Zhang; Daniel Shoun; Afroza Akhtar; Sophie E Darch; Frederick Cohen; Logan D Andrews; John E Knox; Yu Chen
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.